Search details
1.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
N Engl J Med
; 385(1): 46-58, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-34192431
2.
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
Ann Hematol
; 102(4): 863-876, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36862168
3.
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
N Engl J Med
; 377(4): 352-360, 2017 07 27.
Article
in English
| MEDLINE | ID: mdl-28578607
4.
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study.
Jpn J Clin Oncol
; 50(7): 810-820, 2020 Jul 09.
Article
in English
| MEDLINE | ID: mdl-32188988
5.
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 20(5): 686-700, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30987939
6.
Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration-naive prostate cancer: Results from LATITUDE.
Cancer
; 125(4): 626-632, 2019 02 15.
Article
in English
| MEDLINE | ID: mdl-30521063
7.
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data.
Am J Hematol
; 98(9): E255-E258, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37403432
8.
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study.
Jpn J Clin Oncol
; 48(11): 1012-1021, 2018 Nov 01.
Article
in English
| MEDLINE | ID: mdl-30371895
9.
A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects.
Xenobiotica
; 43(4): 379-89, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23020788
10.
Mutant strains of Pichia pastoris with enhanced secretion of recombinant proteins.
Biotechnol Lett
; 35(11): 1925-35, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-23881328
11.
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study.
Amyloid
; 30(3): 268-278, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-36779691
12.
Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.
Amyloid
; 30(2): 161-168, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36282014
13.
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial.
Lancet Haematol
; 10(10): e813-e824, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37793772
14.
Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis.
J Clin Pharmacol
; 62(5): 656-669, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34708423
15.
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial.
JACC CardioOncol
; 4(4): 474-487, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36444227
16.
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302.
Eur J Cancer
; 170: 296-304, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35568679
17.
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study.
Eur Urol
; 77(4): 494-500, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31843335
18.
Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.
Eur Urol
; 76(4): 418-424, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31176622
19.
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
Eur J Cancer
; 84: 88-101, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28800492
20.
NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Biochem Pharmacol
; 72(3): 366-76, 2006 Jul 28.
Article
in English
| MEDLINE | ID: mdl-16765324